Literature DB >> 2969681

Maternal age-specific rates for Down syndrome: changes over time.

P A Baird1, A D Sadovnick.   

Abstract

There have been conflicting reports about whether incidence rates at given maternal ages for Down syndrome (DS) are changing over time. British Columbia provides an excellent opportunity to look at this question as there is 1) nearly complete ascertainment of DS livebirths, 2) a relatively large number of annual births, 3) data on a 20-year time period, 4) data on age-specific fertility rates over this period, and 5) cytogenetic data on all pregnancies terminated through the provincial prenatal diagnosis program since its inception. Data on 856 liveborn DS infants over a 20-year period (1964-1983) were analyzed. Controlling for maternal ages, the data were examined for transient changes in incidence over time and for linear and cyclic trends. No significant (P greater than 0.05) changes in DS incidence were observed over this 20-year period in any maternal age group.

Entities:  

Mesh:

Year:  1988        PMID: 2969681     DOI: 10.1002/ajmg.1320290424

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

Authors:  B Khoshnood; P Pryde; S Wall; J Singh; R Mittendorf; K S Lee
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age.

Authors:  A D Carothers; C A Hecht; E B Hook
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

3.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.

Authors:  Maria Loane; Joan K Morris; Marie-Claude Addor; Larraitz Arriola; Judith Budd; Berenice Doray; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Kari Klungsøyr Melve; Anna Latos-Bielenska; Bob McDonnell; Carmel Mullaney; Mary O'Mahony; Annette Queisser-Wahrendorf; Judith Rankin; Anke Rissmann; Catherine Rounding; Joaquin Salvador; David Tucker; Diana Wellesley; Lyubov Yevtushok; Helen Dolk
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

4.  Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes.

Authors:  W L Kuo; H Tenjin; R Segraves; D Pinkel; M S Golbus; J Gray
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

5.  Increasing total prevalence rate of cases with Down syndrome in Hungary.

Authors:  Julia Métneki; Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 6.  Seasonal variation in the prevalence of Down syndrome at birth: a review.

Authors:  A M Stolwijk; P H Jongbloet; G A Zielhuis; F J Gabreëls
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

7.  Thyroid antibodies as a risk factor for Down syndrome and other trisomies.

Authors:  C P Torfs; B J van den Berg; F W Oechsli; R E Christianson
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

8.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

9.  Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019.

Authors:  Liyuan Chen; Lifei Wang; Yi Wang; Haishan Hu; Yuan Zhan; Zhilin Zeng; Lidan Liu
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.